Products specific to pathogenic strains and their use as vaccines and in immunotherapy
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Aug 24, 2006
app pub date -
Mar 6, 2003
filing date -
Mar 6, 2002
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
The invention relates to isolated antigenic polypeptides obtainable by a process comprising the steps of: 1--selecting on the basis of sequence analysis those of the polypeptides which are either located in the outermembrane or secreted by the bacteria, 2--identifying the genes coding for said polypeptides which are conserved in B2/D clinical isolates, 3--purifying the polypeptides identified in step 1, which are found in step 2 to be conserved in B2/D isolates, 4--testing the polypeptides for immunogenicity using animals models. Application for making vaccines compositions and immunotherapies.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully